The latest announcement is out from Cochlear ( (AU:COH) ).

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear ( ($AU:COH) ) just unveiled an update. Cochlear Limited announced the cessation of certain securities due to the lapse of conditional ...

Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals LONE TREE, ...

Morgan Stanley analyst Sean Laaman downgraded Cochlear Limited (CHEOF – Research Report) to a Sell today and set a price target of A$240.00. The company’s shares closed last Wednesday at $176.30.

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) has issued an ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a biotech company pioneering novel treatments for inner ear diseases, and Cochlear Limited (ASX: COH), ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

CHICAGO (CN) - In a federal class action, a father claims Cochlear Limited's ear implants failed inside his young daughter one month before the FDA recalled them for a manufacturing defect. Wyly Wade ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) just unveiled an ...

Jody McDonald is a freelance writer based in Brisbane who specialises in writing about business, technology and the future of work. She’s helped a range of SaaS platforms and tech companies share ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...